Limited HIV-1 Reactivation in Resting CD4+ T cells from Aviremic Patients under Protease Inhibitors.

about

Targeting TNF and TNF Receptor Pathway in HIV-1 Infection: from Immune Activation to Viral Reservoirs Epigenetic regulation of HIV-1 latency: focus on polycomb group (PcG) proteins.Counteracting Akt Activation by HIV Protease Inhibitors in Monocytes/Macrophages.

P2860

Q33613493-1EB2C712-93A5-4077-961E-D3EF6735A596 Q50022535-8B042E04-D125-4DA3-BE96-D1B156C20670 Q54236415-8D0254BC-DA71-4088-BF1F-092778D8BF1E

P2860

Limited HIV-1 Reactivation in Resting CD4+ T cells from Aviremic Patients under Protease Inhibitors.

Item

http://www.wikidata.org/entity/Q40422107

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Limited HIV-1 Reactivation in ...... nts under Protease Inhibitors.

@en

type

Item

label

Limited HIV-1 Reactivation in ...... nts under Protease Inhibitors.

@en

prefLabel

Limited HIV-1 Reactivation in ...... nts under Protease Inhibitors.

@en

P1476

Limited HIV-1 Reactivation in ...... nts under Protease Inhibitors.

@en

P2093

Amit Kumar

http://www.w3.org/2001/XMLSchema#string

Georges Herbein

http://www.w3.org/2001/XMLSchema#string

Jean-Stéphane Gatot

http://www.w3.org/2001/XMLSchema#string

Kabamba Kabeya

http://www.w3.org/2001/XMLSchema#string

Nathan Clumeck

http://www.w3.org/2001/XMLSchema#string

Sophie Bouchat

http://www.w3.org/2001/XMLSchema#string

Stéphane De Wit

http://www.w3.org/2001/XMLSchema#string

Sébastien Pasquereau

http://www.w3.org/2001/XMLSchema#string

Wasim Abbas

http://www.w3.org/2001/XMLSchema#string

P2860

Epigenetic control of HIV-1 post integration latency: implications for therapy

Casp8p41 generated by HIV protease kills CD4 T cells through direct Bak activation

Decay characteristics of HIV-1-infected compartments during combination therapy

Molecular mechanisms of HIV-1 persistence in the monocyte-macrophage lineage

On-Demand Preexposure Prophylaxis in Men at High Risk for HIV-1 Infection.

Post-treatment HIV-1 controllers with a long-term virological remission after the interruption of early initiated antiretroviral therapy ANRS VISCONTI Study

Choice of antiretroviral therapy differentially impacts survival of HIV-infected CD4 T cells

Multi-step inhibition explains HIV-1 protease inhibitor pharmacodynamics and resistance.

Low-level viremia persists for at least 7 years in patients on suppressive antiretroviral therapy.

Tuning of AKT-pathway by Nef and its blockade by protease inhibitors results in limited recovery in latently HIV infected T-cell line.

P2888

srep38313

P304

38313

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SREP38313

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2016-12-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27922055

http://www.w3.org/2001/XMLSchema#string

P932

5138822

http://www.w3.org/2001/XMLSchema#string

Limited HIV-1 Reactivation in Resting CD4+ T cells from Aviremic Patients under Protease Inhibitors.

about

P2860

P2860

Limited HIV-1 Reactivation in Resting CD4+ T cells from Aviremic Patients under Protease Inhibitors.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P478

P50

P577

P698

P932